Mgta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mgta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mgta Today - Breaking & Trending Today

Magenta Therapeutics (NASDAQ:MGTA) Shares to Split on Thursday, September 7th

Shares of Magenta Therapeutics, Inc. (NASDAQ:MGTA – Free Report) are going to split on the morning of Thursday, September 7th. The 2-1 split was announced on Thursday, September 7th. The newly created shares will be issued to shareholders after the market closes on Thursday, September 7th. Magenta Therapeutics Price Performance Magenta Therapeutics stock opened at […] ....

Magenta Therapeutics Company Profile , Harbor Capital Advisors Inc , Walleye Capital , Jpmorgan Chase Co , Magenta Therapeutics Inc , Acadian Asset Management , Magenta Therapeutics , Free Report , Street Corp , Asset Management , Capital Advisors , Get Free Report , Magenta Therapeutics Daily , Nasdaq Mgta , Stock Split ,

Short Interest in Magenta Therapeutics, Inc. (NASDAQ:MGTA) Rises By 21.2%

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 495,600 shares, an increase of 21.2% from the May 15th total of 408,800 shares. Based on an average daily volume of 504,400 shares, the days-to-cover ratio is […] ....

United Kingdom , Davidt Scadden , Alan Tyndall , Johnf Dipersio , Luigi Naldini , Robert Negrin , Derrickj Rossi , Acadian Asset Management , York Mellon Corp , Health Asset Management , Magenta Therapeutics Company Profile , Magenta Therapeutics Inc , Magenta Therapeutics , Get Rating , Asset Management , New York Mellon Corp , Jason Gardner , Magenta Therapeutics Daily , Nasdaq Mgta ,

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Short Interest Down 56.0% in May

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on […] ....

United Kingdom , Luigi Naldini , Alan Tyndall , Robert Negrin , Davidt Scadden , Johnf Dipersio , Derrickj Rossi , Susquehanna International Group , Magenta Therapeutics Inc , Acadian Asset Management , Group Inc , Atlas Venture Life Science Advisors , Magenta Therapeutics , Get Rating , International Group , Venture Life Science Advisors , Asset Management , Jason Gardner , Magenta Therapeutics Daily , Nasdaq Mgta ,

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Expected to Post Q2 2023 Earnings of ($0.19) Per Share

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – Stock analysts at Wedbush boosted their Q2 2023 earnings per share (EPS) estimates for Magenta Therapeutics in a research report issued on Tuesday, May 16th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.19) for the quarter, up from their […] ....

United Kingdom , Luigi Naldini , Johnf Dipersio , Alan Tyndall , Davidt Scadden , Robert Negrin , Derrickj Rossi , Citadel Advisors , Magenta Therapeutics Inc , Magenta Therapeutics Company Profile , Acadian Asset Management , Walleye Capital , Magenta Therapeutics , Get Rating , Magenta Therapeutic , Therapeutics Stock Down , Asset Management , Jason Gardner , Magenta Therapeutics Daily , Nasdaq Mgta , Earnings Estimates ,

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Sees Significant Drop in Short Interest

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,060,000 shares, a drop of 10.9% from the March 31st total of 1,190,000 shares. Currently, 2.4% of the company’s shares are short sold. Based […] ....

United Kingdom , Davidt Scadden , Alan Tyndall , Robert Negrin , Luigi Naldini , Johnf Dipersio , Derrickj Rossi , Thrivent Financial For Lutherans , Morgan Stanley , Renaissance Technologies , Millennium Management , Magenta Therapeutics Inc , Magenta Therapeutics , Get Rating , Sigma Investments , Thrivent Financial , Jason Gardner , Magenta Therapeutics Daily , Nasdaq Mgta ,